Serina Therapeutics SER
NYSE SER
$1.51 +0.08 (+5.59%)
As of: Nov 11, 2026 · 3:59 PM EST

Serina Therapeutics (SER) Price to Book (2018 - 2026)

Updated

Serina Therapeutics' (SER) Price to Book came in at 1.70 for Q2 2026, down 95.5% from 37.97 a year earlier.

Analysis

Serina Therapeutics (SER) Price to Book (2018 - 2026) Analysis & Trends

For FY2024, Serina Therapeutics' Price to Book stood at 72.58.

  • The Q2 2026 figure stands as the lowest quarterly Price to Book in data going back to Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Serina Therapeutics 23.59 Mn -35.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.70
Mar 31, 2026 1.33
Sep 30, 2025 32.11
Jun 30, 2025 37.97
Mar 31, 2025 36.12
Dec 31, 2024 72.58
Dec 31, 2019 935.11
Sep 30, 2019 533.16
Jun 30, 2019 665.88
Mar 31, 2019 542.81
Dec 31, 2018 464.86
API Access

Serina Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=SER&period=max&api_key=YOUR_API_KEY